Lack of Activity of Sulfamethoxazole and Trimethoprim Against Anaerobic Bacteria

The activity of sulfamethoxazole (SMX), trimethoprim (TMP), and the combination of the two was determined against a variety of anaerobic bacteria. Brucella agar was somewhat inhibitory for SMX and TMP but activity was good and equivalent in Diagnostic Sensitivity Test Agar (Oxoid) and Mueller-Hinton agar and the latter was selected for use in these studies. Agar dilution susceptibility tests showed that 95 of 98 anaerobic isolates were resistant to ≥100 μg of SMX per ml and 85 were resistant to ≥6.25 μg of TMP per ml. “Checkerboard” agar dilution studies of combined activity showed that 66 of 72 isolates were resistant to ≥ (100 μg of SMX per ml + 6.25 μg of TMP per ml) and only six isolates were susceptible to the synergistic activity of the combination. The majority of 32 isolates tested by the disk diffusion method were also resistant to SMX and TMP individually and to the combination 25-μg disk. Correlation between agar dilution minimal inhibitory concentration and disk zone size results was in general good for individual agents. Four Bacteroides fragilis isolates were inhibited by the combination 25-μg disk but were resistant to SMX + TMP by agar dilution “checkerboard.” This discrepancy may have been due to different incubation periods since disk results also showed resistance when read after 48 h (as is done with agar dilution) rather than the standard 24 h for disk tests. These studies suggest that SMX and TMP, either individually or in combination, are not active against the great majority of anaerobic bacteria.

[1]  S. Bushby,et al.  Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. , 1973, The Journal of infectious diseases.

[2]  O. Okubadejo,et al.  Bacteroides in the blood. , 1973, Lancet.

[3]  G. Masterton,et al.  Gonorrhea in women: treatment with sulfamethoxazole and trimethoprim. , 1971, The Journal of infectious diseases.

[4]  J. Burchall,et al.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. , 1971, Applied microbiology.

[5]  D. Reeves Sulphamethoxazole-trimethoprim: the first two years. , 1971, Journal of clinical pathology.

[6]  S. Kamat Evaluation of Therapeutic Efficacy of Trimethoprim-sulphamethoxazole and Chloramphenicol in Enteric Fever* , 1970, British medical journal.

[7]  S. Lal,et al.  Comparison of tetracycline and trimethoprim-sulphamethoxazole in acute episodes in chronic chest infections. , 1969, Postgraduate medical journal.

[8]  Waterworth Pm Practical aspects of testing sensitivity to trimethoprim and sulphonamide. , 1969 .

[9]  E. Steers,et al.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics. , 1959, Antibiotics & chemotherapy.

[10]  H. Näff [Changes in the intestinal flora induced in man by Bactrim]. , 1971, Pathologia et microbiologia.

[11]  H. Näff Über die Veränderungen der normalen Darmflora des Menschen durch Bactrim , 1971 .

[12]  P. Waterworth Practical aspects of testing sensitivity to trimethoprim and sulphonamide. , 1969, Postgraduate medical journal.

[13]  L. Sabath Synergy of antibacterial substances by apparently known mechanisms. , 1967, Antimicrobial agents and chemotherapy.